Earnings summaries and quarterly performance for Amesite.
Research analysts covering Amesite.
Recent press releases and 8-K filings for AMST.
Amesite Inc. Announces Q2 2026 Revenue Increase and EMR Product Plans
AMST
Earnings
Product Launch
Revenue Acceleration/Inflection
- Amesite Inc. reported a 69% quarter-over-quarter (QoQ) revenue increase in Q2 2026, following an 82% QoQ increase in the previous quarter, while simultaneously reducing operating expenses.
- The company is actively developing and plans to launch the industry's first AI-powered electronic medical record (EMR) platform for post-acute care by 2026, with billing services targeted for delivery in November 2025 and the goal to close its first full EMR customer in Q2 2026.
- As of September 30, 2025, Amesite Inc. held nearly $2 million in cash on hand and reported zero debt.
Oct 30, 2025, 11:30 AM
Amesite Announces Q2 2026 Revenue Growth and AI-Powered EMR Plans
AMST
Earnings
Revenue Acceleration/Inflection
Product Launch
- Amesite Inc. announced a 69% quarter-over-quarter (QoQ) revenue increase and reduced its spending.
- The company is expanding its customer base and offerings to post-acute health businesses across the U.S., with customer engagement accelerating since Q1 2026.
- Amesite plans to launch what it believes is the industry’s first AI-powered electronic medical record (EMR) platform for post-acute care by 2026.
Oct 30, 2025, 10:30 AM
Amesite Reports Revenue Growth and New AI Product Launch
AMST
Revenue Acceleration/Inflection
Product Launch
- Amesite Inc. announced 63% revenue growth for its NurseMagic\u2122 platform.
- This growth follows the launch of its census-based Enterprise subscription model on July 14, 2025, resulting in Enterprise sales surpassing B2C sales.
- The company also launched an AI-powered automated form fill solution for government forms, designed to assist post-acute care providers with the upcoming CMS Hospice Outcomes and Patient Evaluation (HOPE) assessment mandate in October.
Sep 11, 2025, 10:30 AM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more